The Department of Medicine is honored to announce that Sandeep K. Mallipattu, M.D., FASN, Division Chief of Nephrology and Hypertension, has been selected to serve as a member of the National Institute of Health's Pathobiology of Kidney Disease Study Section, Center for Scientific Review.
As outlined by Noni Byrnes, Ph.D., Director, Center for Scientific Review in the NIH Department of Health and Human Servies: "Members are selected on the basis of their demonstrated competence and achievement in their scientific discipline as evidenced by the quality of research accomplishments, publications in scientific journals, and other significant scientific activities, achievements and honors. Service on a study section also requires mature judgment and objectivity as well as the ability to work effectively in a group, qualities we believe Dr. Mallipattu will bring to this important task."
Dr. Mallipattu is Chief of the Division of Nephrology and Hypertension, Stony Brook Medicine, and a DCI-Martin Liebowitz Associate Professor of Medicine in the Renaissance School of Medicine, Stony Brook University. He is recognized for his research on identifying molecular mechanisms involved in the progression of chronic kidney disease. Specifically, he investigates the mechanisms by which modulating gene expression effects some of the most fundamental cellular processes in the kidney, with the ultimate goal of identifying novel pathways that could be targeted for therapy.
Dr. Mallipattu earned a BS in Biomedical Engineering at the University of California, San Diego, then earned his MD from Boston University School of Medicine, and completed his Internal Medicine and Nephrology Fellowship at Icahn School of Medicine at Mount Sinai.
Among his many accolades, Dr. Mallipattu was named a 2019 PECASE recipient (the highest honor bestowed by the US government to outstanding scientists and engineers at the outset of their independent research careers), a 2019 Stony Brook University Discovery Prize finalist and was recently elected to participate in the inaugural class of the SUNY Clinical Leadership Academy. He is also the Renaissance School of Medicine representative that is co-leading the The New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research with Columbia University and Albert Einstein College of Medicine.
Dr. Byrnes continues: "Membership on a study section represents a major commitment of professional time and energy as well as a unique opportunity to contribute to the national biomedical research effort. Study sections review grant applications submitted to the NIH, make recommendations on these applications to the appropriate NIH national advisory council or board, and survey the status of research in their fields of science. These functions are of great value to medical and allied research in this country."
The Department of Medicine is extremely proud to make this announcement on behalf of Dr. Mallipattu, and we congratulate him on this wonderful honor. We recognize the importance of Dr. Mallipattu's participation, and we thank him for tireless contributions to his division, our department, our institution and the Stony Brook community.
